Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
Reversal of Dense Signs Predicts Recovery in Acute Ischemic Stroke
Stroke 36:e2490-e2492, Mandava,P. &Kent,T.A., 2005
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002
How Do You Manage Patients with a "Hot Carotid"?
Neurol:Clin Pract 8:527-536, Ganesh,A.,et al, 2018
Summary of Evidence-Based Guideline: Periprocedural Management of Antithrombic Medications in Patients with Ischemic Cerebrovascular Disease
Neurol 80:2065-2069, Armstrong, M.,et al, 2013
Management of Anticoagulation Before and After Elective Surgery
www.uptodate.com Dec. 2012, Lip, G. & Douketis, J., 2012
Extracranial Arterial Dissection, Angicoagulation Is the Treatment of Choice: Against
Stroke 36:2042-2043,2043, Lyrer,P.A., 2005
Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003
Anticoagulants Versus Antiplatelet Agents for Acute Ischemic Stroke
Stroke 34:1571-1572, Berge,E. &Sandercock,P., 2003
Intracerebral Hemorrhages Associated with Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab
Stroke 33:1916-1919, Qureshi,A.I.,et al, 2002
Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002
Tinzaparin in Acute Ischaemic Stroke (TAIST):A Randomised Aspirin-Controlled Trial
Lancet 358:702-710,683, Bath,P.M.W.,et al, 2001
Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001
Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000
Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999
Intl Stroke Trial:Random Trial of ASA
Subcut Heparin, Both, or Neither Among 19435 Pts with Ischaemic Stroke, IST Collab Grp, Lancet 349:1, 69-11997., 1997
Drugs and Surgery in the Prevention of Ischemic Stroke
NEJM 332:238-248, Barnett,H.J.M.,et al, 1995
A Follow-up Survey of Clinical Practices for the Use of Heparin, Warafarin, & Aspirin
Neurol 44:618-621, Alberts,M.J.,et al, 1994
Antithrombotic Therapy in Acute Ischaemic Stroke:An Overviews of the Completed Randomized Trials
JNNP 56:17-25, Sandercock,P.A.G.,et al, 1993
The Management of Acute Visual Failure
JNNP 56:234-240, Wray,S.H., 1993
Diagnosis and Treatment of Ischemic Stroke
JAMA 266:2413-2418, Caplan,L.R., 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
A Randomized Trial of Aspirin or Heparin in Hospitalized Patients with Recent Transient Ischemic Attacks:A Pilot Study
Stroke 20:441-447, Biller,J.,et al, 1989